Abstract-The deoxycorticosterone acetate (DOCA)salt mouse model exhibits adverse cardiac remodeling in male mice and cardiac protection in female mice, even when blood pressure is normalized. We hypothesized that intact mammalian target of rapamycin (mTOR) signaling is necessary for cardiac protection in females. We first tested sex differences and intracellular signaling after mTOR targeting with rapamycin in wildtype mice. Radiotelemetric blood pressure was maintained at normal for 6 weeks. Rapamycin significantly reduced left ventricular hypertrophy, preserved ejection fraction, inhibited fibrosis, and maintained capillary structure in male mice. Decreased mTORC1 and increased mTORC2 activity were detected in rapamycintreated male mice compared with vehicle controls. In contrast, female mice developed dilative left ventricular hypertrophy, cardiac fibrosis, and capillary loss similar to DOCAsalt females lacking the estrogen receptor β (ERβ −/− ) that we described earlier. Because rapamycin downregulated ERβ in female mice, we next studied ERβ −/− normotensive DOCA salt females. Vehicletreated wildtype females maintained their high constitutive mTORC1 and mTORC2 in response to DOCAsalt. In contrast to males, both mTORCs were decreased by rapamycin, in particular mTORC2 by 60%. ERβ −/− DOCAsalt females showed similar mTORC1 and mTORC2 response patterns. We suggest that ERβdependent regulation involves sexspecific use of mTOR signaling branches. Maintenance of both mTORC1 and mTORC2 signaling seems to be essential for adaptive cardiac remodeling in females and supports a rationale for sexspecific therapeutic strategies in left 
W omen enjoy a lower prevalence and slower pro gression of cardiovascular and renal diseases.
1,2 Sex chromosomes 3, 4 and sex hormones 5, 6 are involved in the development of hypertension and progression of cardiovascular disease in both men and women. Many clinically observed sex differences can be reproduced in animal rodent models, such as spontaneously hypertensive rats to more complex models with deoxycorticosterone acetate (DOCA)salt treatment. 7, 8 Sexual dimorphism with adverse cardiac remodeling in males and maintenance of protective phenotype in females is retained even when blood pressure is normalized in DOCA salt mice. 9 Active calcineurin signaling induced maladaptive left ventricular hypertrophy (LVH) in male DOCA mice, yet was dispensable in female mice. 9 Gene deletion of estrogen receptorβ (ERβ −/− ) reduced cardiac protection in female mice without relevant changes in calcineurin pathway activation, implicating the importance of alternative pathways. 10 We hypothesized that preserved physiological signaling, rather than the induction of maladaptive responses, may be instrumental for female cardioprotection. We focused on mammalian target of rapamycin (mTOR) signaling, which functions as the catalytic subunit of 2 mTORcontaining, functionally distinct signaling complexes, mTORC1 and mTORC2.
11 mTOR serves as a nodal point in both adaptive and maladaptive cardiac hypertrophic responses. 12 We targeted mTOR with rapamycin to study sexspecific differences in mTOR signaling.
As pharmacological targeting of mTOR induced maladap tive cardiac phenotype restricted to female mice resembling ERβgenomic deletion, we further studied the interaction of ERβ with mTORC1 and mTORC2 activities in ERβ −/− mice.
mice (C57BL/6JRccHsd from Harlan Winkelmann, Germany) were uninephrectomized (UniNx) and immediately implanted subcutane ous DOCApellet. They were exposed to salt (1% NaCl in drinking water) and treated with hydralazine (250 mg/L in drinking water) for bloodpressure normalization. Rapamycin (low concentration 1.5 mg/ kg) or vehicle was administered intraperitoneally starting from postop erative day 5 every third day until the end of the experiment (day 42). In total, 8 experimental groups including 9 to 15 mice per group, were studied. Additional highconcentration group (4.5 mg/kg) was added for control purposes. All animals were characterized by MRI for body composition analysis, echocardiography, and blood pressure at the end of experiment. After completion of functional recordings, hearts were excised, weighed, snap frozen in liquid nitrogen, and stored at −80°C for further analysis. Rapamycin serum trough levels were determined by microparticle assay (ARCHITECT, Abbott).
Blood Pressure, Hemodynamics, and Echocardiography
Telemetric recordings were performed in additional 7 female and male mice as previously described. 10 The experiment was divided into 3 parts which contain baseline, uninephrectomy+salt, and DOCAsalt, hydral azine and rapamycin intervention. Additionally, mean arterial pressure was also recorded under anesthesia via carotid artery catheterization in all other mice. A highresolution Vevo770 echocardiography system (mouse specific transducer RMV707B, Visual Sonics, Canada) was used for Mmode tracings recorded from shortaxis.
Histology, Immunohistochemistry, and Morphometry
Collagen was stained with picrosirius red and the amount of extra cellular depositions was calculated as percentage per fields of view. Endothelial marker, platelet endothelial cell adhesion molecule1 (PECAM1) was detected with polyclonal goat antibody (Santa Cruz Biotechnology, Inc). A biotinylated antigoat antibody and a catalyzed signal amplification system (Dako, Germany) were used for signal amplification.
Analysis of Gene Expression by Quantitative RealTime Polymerase Chain Reaction
Total RNA was extracted with PerfectPure RNA tissue kit (5Prime), purified and reverse transcribed into cDNA with ran dom hexamer primers, as previously described. 9 Specific oli gonucleotide primers for vascular endothelial growth factor (VEGF) (forward 5′CAGGCTGCTGTAACGATGAA3′, reverse 5′GCATTCACATCTGCTGTGCT3′) were synthesized (TIB MolBiol, Berlin) and realtime polymerase chain reaction was per formed in the 7500 Fast RealTime PCR system (Applied Biosystems). The relative amount of gene transcript was calculated by the cycle threshold and normalized for endogenous reference, β2 microglobulin.
Western Blot Analysis
Cardiac tissue was prepaired for blotting according to previously described procedures. 10 Additional heart lysates from normoten sive male and female ERβ −/− DOCAsalt mice were also analyzed. 10 Membranes were incubated with primary antibodies against phospho p70S6K Thr389 and phosphoAkt Ser473 (both Cell Signaling Technology), ERβ (1531; Santa Cruz Biotechnology Inc), and αTubulin or GAPDH (Sigma, and HyTest, Finland) for normalization. Specific bands were quantified using Gene Tools 4.02 software.
Statistics
Data are shown as mean±SEM with 3FANOVA for sextreatment intervention interaction, and appropriate 2FANOVA analyses were conducted for all of the data sets. Only significant interactions with a P value ≤0.05 are given with partial Etasquared (η p 2 ) as a measure of effect size. For comparison of multiple groups, 1way ANOVA was performed followed by posttesting with Bonferroni multiple com parisons test. P value at P≤0.05, P≤0.01, and P≤0.001, respectively, were considered as statistically significant. All tests were performed using SPSS Statistics 20.0.0 (IBM) for Windows.
Please see the onlineonly Data Supplement for detailed Methods regarding animal model and interventions, determination of rapamycin levels, body composition analysis, hemodynamic recordings and echo cardiography, immunohistochemistry, morphometry, analysis of gene expression by quantitative realtime PCR, and Western blot analysis.
Results
We first aimed to exclude potential confounders in our model. Thereby, we neither found gender nor treatmentspecific differ ences in our animals related to DOCAsalt or rapamycin inter vention ( Figure S1 in the onlineonly Data Supplement). Blood pressure was well controlled in all groups (Figure 1 ; Figure  S1B ). Rapamycin (1.5 mg/kg) was monitored by trough serum levels showing biologically relevant ranges (3-4 ng/mL) used in mouse models of polycystickidney disease. 13 Trough levels in males were as follows: UniNx, 3.9±0.4 ng/mL and DOCA salt, 4.2±0.7 ng/mL. Females reached similar levels: UniNx, 4.3±1.4 ng/mL and DOCAsalt, 3.3±0.2 ng/mL. Higher trough concentrations (8-10 ng/mL) were achieved with 4.5 mg/kg. Because no additional biological effects on cardiac indices were observed, we focused on the low concentrations.
As previously reported, 9, 10 DOCAsalt induced stronger LVH in males than females as assessed by heart weightto tibia length ratios (heart weight/tibia length), 27% increase in males, and 15% increase in females (Figure 2A ; Table) and shown macroscopically ( Figure 2B ) under normotensive conditions. Increase in relative cardiac mass was associated with increased ventricular septum and LV posterior wall thicknesses without changes in LV inner diameter ( Figure 2C and 2D; Table) , demonstrating concentric LVH in response to DOCAsalt treatment in both male and female mice, which was more pronounced in males. Pharmacological targeting of mTOR revealed striking sexual dimorphism. Rapamycin attenuated concentric LVH characterized by reduced heart weight/tibia length increases (9%) and lean heart macroscopy with unchanged increased ventricular septum and LV inner diameter in male DOCA mice (Figure 2A-2D ; Table) . However, rapamycin disturbed cardiac adaptation in all female groups. Trend toward decreased relative cardiac mass, thinner increased ventricular septum, and LV posterior wall thicknesses on rapamycin was observed in UniNxsalt control ( Figure 2A , 2C, and 2D; Table) . In contrast to males, rapamycin worsened LVH in DOCA females, who developed a further 38% increase in heart weight/tibia length and dilated hearts characterized by reduced wall thicknesses and increased LV inner diameter (Figure 2A-2D ; Table) . Beneficial effect of rapamycin in males was further extended to less fibrosis ( Figure 3A and 3B). Preserved VEGFmRNA expression and PECAM staining of endothelium impli cated maintenance of vascular integrity ( Figure 3C and 3D) . Rapamycintreated DOCA females showed the opposite pic ture with prominent Sirius Red staining ( Figure 3A and 3B) in parallel to decreased VEGFmRNA expression and almost absent PECAM ( Figure 3C and 3D ), which contrasted with vehicletreated females displaying female sexrelated intrinsic resistance to fibrosis on stress stimuli.
We further investigated how sex differences in cardiac adaptation after rapamycin could be explained by the targets, mTORC1 and mTORC2.
14 Phosphorylation of downstream kinase p70S6K at Thr389 served for assessing mTORC1 activity and pAkt at Ser473 reflected mTORC2. Females had higher intrinsic levels of both mTORC1 and mTORC2 downstream kinases pp70S6K
Thr389 and pAkt
Ser473
, compared with males ( Figure 4A and 4B). Rapamycin reduced pp70S6K
Thr389 in all groups ( Figure 4A ). Rapamycinmediated reduced mTORC1 activation was associated with increased mTORC2, as reflected by increased pAkt Ser473 ( Figure 4B ) in male mice. In striking contrast, rapamycin significantly reduced mTORC2 activity in all female mice studied.
We next hypothesized that rapamycin could impair ERβ expression in females. 10 Cardiac expression of ERβ protein increased in response to DOCAsalt in female mice ( Figure  5A ). Rapamycin treatment not only precluded compensatory upregulation in ERβ expression, but also strongly decreased ERβ expression far below the constitutive level observed in UniNx controls ( Figure 5A ). To further address possible functional relation between ERβ and signaling via distinct mTOR complexes, we used hearts from normotensive ERβ 
Discussion
Our important finding is that mTOR targeting by rapamycin induced sexually dimorphic myocardial adaptation at normo tensive conditions in a DOCAsalt model. Rapamycin helped only male mice as confirmed by anatomic and functional stud ies. Our data suggest that prevention of maladaptive cardiac remodeling was accompanied by decreased mTORC1, in par allel to increased mTORC2 signaling effectors. In contrast, rapamycin induced severe maladaptive cardiac response in female mice, reminiscent of ERβ deletion. In females, both, mTORC1 and mTORC2 signaling were strongly inhibited by rapamycin and profound downregulation of ERβ was observed. Impaired signaling via mTORC1 and mTORC2 was replicated in ERβ −/− mice. These findings underscore the importance of intact ERβ, mTORC1, and mTORC2 signaling effectors for intrinsic cardioprotection in female mice.
Similar to our data obtained on male mice, rapamycin ameliorated cardiac remodeling in various rodent mod els of cardiac loadinduced 15 or uremic cardiomyopathy. 16 Rapamycin is primarily considered as a selective mTORC1 inhibitor. Compromised structural integrity of mTORC1 and allosteric reduction of specific kinasedomain activ ity may be responsible mechanisms. 17 In agreement with our study, rapamycin suppressed p70S6K, as an indica tor of mTORC1 activity. Beneficial cardiac remodeling in rapamycintreated (clinically used derivative) cardiac transplant patients with improved LVH and cardiac func tion was also reported. 18 Moreover, deletion of the defin ing mTORC1 protein, raptor, in male mice 19 or rapamycin intervention in a rat pulmonarybanding model 20 have been shown to activate mTORC2, most probably attributable to a release of a negative feedback inhibition as occurs in can cer. 21 However, these studies did not investigate mTORC2 in female mice or female patients. Sex differences in response to mTOR inhibition have been observed in the Han:SPRD (Cy/+) rat, a polycystickidney disease model. 22 Similar to our model, beneficial effects were observed only in males, whereas cyst size remained unaffected in females. 22 However, in these cystic kidneys rapamycin inhibited mTORC2 only in males and not in females. Our findings, that relatively low concentrations of rapamycin inhibited both mTORC1 and mTORC2 in females, together with the difference in maladaptive cardiac responses in males and females is novel. These effects were not attrib uted to sex differences in pharmacokinetics excluded by closely monitored serum trough levels. mTORC1 and mTORC2 are regulators of protein and lipid synthesis, mitochondrial function, energy metabolism, and cell survival. 23 Both mTORC1 and mTORC2 are activated by growth factors including insulin-like growth factor-1 (IGF-1), a prototypic mediator of adaptive cardiomyocyte responses. 24 Unlike males, female mice had high constitutive activity of both mTOR signaling branches. mTORC1, as reflected by p70S6K phosphorylation at Thr389 and mTORC2, reflected by Akt phosphorylation at Ser473, which seemed to be essen tial for maintaining adaptive cardiac responses. Both are downstream from PI3K signaling. High levels of nuclear localized pAkt is considered as a hallmark of female sexspe cific cardioprotection. 25 Nuclear localization of pAkt requires phosphorylation, not only phosphatidylinositide 3kinase (PI3K)dependent phosphorylation by phosphoinositide dependent kinase 1 (PDK1) at Thr308, but also at Ser473, which requires intact mTORC2. 26, 27 Thus, pharmacological targeting of mTOR interferes with adaptive pathways con sidered to mediate endogenous cardiac protection in females. This hypothesis is supported by the downregulation of ERβ in response to rapamycin, as well as similar dysregulation of 30 and may mediate such nongenomic signaling.
However, exact signaling cascades activated by ERβ are less clear than those of ERα. 31 In our previous study, ERβ −/− females developed worse fibrosis and larger impairment in cardiac performance, when compared with DOCAsalt wild type males, which could not be explained by higher activa tion of signals mediating maladaptive growth. 9, 10 A tightly regulated balance between mTORC1 and mTORC2 signaling may represent an instrumental pathway involved in female endogenous protection. Rapamycintreated females had a high degree of fibrosis similar to ERβ −/− females and impaired VEGF synthesis as observed in tumor biology. 32 Because ovariectomy may lead to disturbed ER expression and sub cellular distribution 30 with disturbed signaling, we decided to study native mice in parallel to ERβ −/− mice. Finally, mTORC2 function increased in males after rapamy cin, whereas it significantly decreased in females. Concordantly, the cardiac phenotype improved in DOCAsalt males but wors ened in DOCAsalt females. In contrast to mTORC1, upstream regulators of mTORC2 are largely unknown. Recent studies in yeast and subsequent experiments in mammalian cells impli cate ribosomes as upstream regulators of mTORC2. 33 A better understanding of the mechanisms of how estrogens or ER may influence ribosome content and thereby mediate adaptive car diac responses would be of great interest.
Perspectives
Sex differences warrant elucidation so that both genders may benefit. The mTOR differences in signaling we observed in our study may lead to TORC2directed therapies that could be indi vidualized for men and women. Furthermore, because ER and mTORdirected therapies are commonly used in cancer, poten tial cardiac sequels warrant particular attention in such patients. • Our data clearly show male/female differences in mammalian target of rapamycin (mTOR)-pathway signaling relevant to maladaptive cardiac response in a blood pressure-normalized deoxycorticosterone acetatesalt mouse model. The novel findings implicate sex-specific use of mTOR signaling branches.
What Is Relevant?
• Aside from identifying this complex as a therapeutic target for heart disease, our results have implications for cancer patients who may develop heart disease during therapy.
Summary
Estrogen receptor β-dependent regulation of cardiac remodeling in normotensive deoxycorticosterone acetate-salt model involves sex-specific use of mTOR signaling branches. Maintenance of both mTORC1 and mTORC2 signaling seems to be essential for adaptive cardiac remodeling in females and supports a rationale for sexspecific therapeutic strategies in left ventricular hypertrophy.
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SUPPLEMENTAL METHODS
Animal model and interventions
Local authorities (LaGeSo G0028/11, Berlin, Germany) approved the protocol and all studies were performed according to the animal care guidelines of the Medical Faculty of Charité. Ten weeks old male and female mice (C57BL/6JRccHsd from Harlan Winkelmann, Germany) were housed under standardized conditions. All mice underwent unilateral nephrectomy (Uni-Nx) via flank incision under 1-1.5% isoflurane anesthesia. Single injection of buprenorphin followed by tramadol was applied for analgesia management. After operationand continuously for 6 weeks mice received 1% saline in drinking water. Male and female mice were then allocated to either control groups (Uni-Nx + salt) or were additionally exposed to mineralcorticoid excess by subcutaneous implantation of a DOCA pellet (75 mg DOCA/pellet; SM-121, Innovative Research of America, USA) with 60-day release time taking place within the same intervention as the nephrectomy. Animals with DOCA pellets additionally had 250 mg/L hydralazine (Sigma-Aldrich, Germany) in their drinking water to prevent a DOCA-salt induced increase in blood pressure (DOCA+salt+hydralazine). In addition, mice of both sexes underwent vehicle or pharmacological intervention with rapamycin, respectively. Rapamycinor vehicle was infused intraperitoneally (i.p.) rapamycin1.5 mg/kgevery third daystarting from day 5 after initial operation and was carried out until the end of the experiment after 42 days. Additional "highconcentration" group (4.5 mg/kg) was added for control purposes. In total, 8 experimental groups with 9-15 animals were investigated.
Additionally, 7 mice of both sexeswere used to constantly monitor systemic blood pressure. Mice under telemetric blood pressure recording underwent radiotransmitter implantation prior to the experiment. Animals were allowed to recover for 14 days after which a unilateral nephrectomy was performed. From that time the animals received salt (1% NaCl) with their drinking water. After another 14 days, the mineralocorticoid challenge was induced by DOCA-pellet implantation. Hydralazine (250 mg/L) was applied to the drinking water in addition to salt to normalize blood pressure. 5 days after DOCA-pellet implantation i.p. injections with either vehicle or rapamycin1.5 mg/kg was carried out on every third day until day 42 of mineralocorticoid challenge.
After treatment of 6 weeks all animals were characterized by MRI body composition analysis, echocardiography, and invasive blood pressure measurements. Blood samples were taken immediately after removing the blood pressure catheter of the carotid artery. Hearts were instantly excised, weighed, snap frozen in liquid nitrogen and stored at -80°C for further analysis.
Rapamycin serum levels
For determination of rapamycin trough levels blood samples were collected and stored at 4°C until analysis but for a maximum of 24h. The analysis was performed at the central laboratory of the Charité on Campus Virchow-Klinikum Berlin by the use of an ARCHITECT i2000 sirolimus assay (Abbott, USA) in accordance to manufactures instruction.
Body composition analysis
Conscious mice were placed in an NMR spectroscopy device EchoMRI-100™ for mice (Echo Medical Systems, USA) using an animal holder for mice prescribed for a weight of 20 g, and measurements were repeated 3 times in accordance with the manufacturer's instructions. Total body water content was related to lean mass to disregard differences in adipose tissue.
Hemodynamic recordings
In final measurements of mean arterial pressure (MAP), mice were anesthetized with 1-1.5% isoflurane mixed with 0.5 L/min 100% O 2 and a pressure catheter (Preclin 420, control unit 201, both Samba Sensors, Sweden) was placed into the aorta via right carotid artery.Telemetric recordings were performed in additional 7 female and male mice as described previously. 1 In brief, the pressuresensing catheter PhysioTelPA-C10 (Data Sciences International (DSI), USA) was advanced via the carotid artery into the ascending aorta, and the transmitter was placed in a subcutaneous pocket. All mice were allowed to recover for 14 days while baseline blood pressure (BP) was recorded. By this time, the mice had regained their circadian BP and HR rhythm, and the surgery and anesthesia-dependent initial changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), and HR were followed. The mice were uninephrectomized and subjected to 1% NaCl in their drinking water for 14 days. Thereafter DOCA pellet was implanted, hydralazine (250 mg/L) was applied additionally to salt and rapamycin intervention was carried out for 6 weeks starting 5 days after pellet implantation. Data were collected over 24h continuously for 10 s every 5 minutes and analyzed using DATAQUEST software (A.R.T. 2.1; DSI, USA).
Echocardiography
For detailed echocardiographic analysis a high resolution Vevo770 system (mouse specific transducer RMV707B, 15 -45 MHz, VisualSonics, Canada) was used. Two-dimensional images and M-mode tracings were recorded from the shortaxis view at the high papillary muscle level. Before mice were anesthetized using 1.5 -2% isoflurane mixed with 0.5 L/min 100% O 2 , fur was removed from the chest with depilatory cream and the animals were placed supine on a 37°C tempered platform with all legs taped to electrocardiography electrodes for heart rate monitoring. Following parameters were assessed using M-mode in end-systolic and end-diastolic situation: thickness of the interventricular septum ( 
Histology, immunohistochemistry, and morphometry
Formalin-fixed and paraffin-embedded heart sections (2 μm) were dewaxed and rehydrated using a standard histology protocol. Stained heart sections were visualized under a light microscope (Zeiss Axio Imager A1, Carl Zeiss, Germany) and quantified using a digital imaging system (Zeiss Axiocam HR with Axiovision 4.4 software, Carl Zeiss). Myocyte cross-sectional area (MCA) was assessed after staining with hematoxylin(Merck, Germany), and periodic acid-Schiff (Merck) at 400x magnification. A minimum of 100 cardiomyocytes per mouse out of randomly selected fields of view (FOV) were collected for calculating the MCA in µm 2 as mean ± SEM (n = 8-12 per group).
Collagen was stained with picro-sirius red according to a standard protocol employing Direct Red 80 (Sigma) and saturated aqueous solution of picric acid (1.3% in water) (Sigma). Extracellular collagen deposition in red was binarized and calculated as percent of total stained area per FOV at 400x magnification in 10 random FOVs per section (n = 6 per group). Results were expressed as mean ± SEM of % stained area per FOV at 400x magnification.
Endothelial marker, PECAM-1 was detected with polyclonal goat antibody (PECAM-1 clone M-20, # sc-1506-R; Santa Cruz Biotechnology, Inc., USA). Phospho-p44/42 MAPK (ERK1/2(Thr202/Tyr204)) was detected with a monoclonal rabbit antibody (clone 197G2; # 4370 from Cell Signaling Technology (CST), USA) at a dilution of 1:3000. A biotinylated secondary anti-rabbit antibody and a catalyzed signal amplification system (Dako, Germany) based on the streptavidin-biotinperoxidase reaction were used for staining in accordance to the instructions of the manufacturer. Isotype control IgG served as control.
Analysis of gene expression (qRT-PCR)
Total RNA from a piece of the LV was extracted with a PerfectPure RNA tissue kit (5Prime, USA) purified and reverse transcribed into cDNA with random hexamer primers, as previously described 8 . Specific oligonucleotide primers were synthesized by TIB MolBiol (Berlin, Germany). Real-time PCR was performed in the Applied Biosystems 7500 Fast Real-Time PCR system (Applied Biosystems, USA). 20 μl volume was used for PCR reactions containing 2 μl of cDNA, specific sense and anti-sense primers (50 nM each), and 10 μl Power SYBR Green PCR Master Mix (Applied Biosystems). Primer sequences were as follows:VEGF (NCBI Reference Sequence: NM_001025250.3) forward 5'-CAGGCTGCTGTAACGATGAA-3' and reverse 5'-GCATTCACATCTGCTGTGCT-3'), β2-microglobulin (GenBank NM_009735.3) forward (5'-GAAATCCAAATGCTGAAGAACG-3'), reverse (5'-CAAATGAATCTTCAGAGCATCATG-3'). After an initial activation step for 2 min at 50°C and denaturation at 95°C for 10 min, 40 cycles of 15 sec at 95°C, and 1 min at 60°C were performed. Specificity of the reaction was verified by melting curve analysis at the end of each series of assays. The relative amount of gene transcript was calculated by the cycle threshold method using the Applied Biosystems 7500 System v.1.2.3 software and normalized for the endogenous reference (β2-microglobulin).
Western Blot Analysis
Pieces of frozen left ventricular tissue were transferred into tubes containing 1.4 mm ceramic lysis matrix (Precellys24, Peqlab, Germany) and homogenization was achieved in a tissue disruptor for 2 x 20 sec (FastPrep®24, MP Biomedicals, USA) with ice cold lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 1% Igepal CA-630, 0,1% SDS,1 mM sodium vanadate, 2 mM sodium pyrophosphate, 10 mM sodium fluoride, 10 mM ß-glycerophosphate, and complete protease inhibitor cocktail (Complete Mini, Roche Diagnostics, Switzerland). Lysis was completed on ice for 20 min. Extracts were cleared by centrifugation (4°C, 15 min, 14,000 rpm), and protein concentrations were measured with the Bradford method. Aliquots with 40 µg total protein content were boiled in SDS-Laemmli buffer with 100 mM DTT for 5 min. Samples were loaded onto 10% Bis-Trispolyacrylamid gels and separated by electrophoresis. Proteins were then transferred onto nitrocellulose membranes (GE Healthcare, Sweden) that were blocked for 1 h at room temperature with 5% nonfat milk (AppliChem, Germany) and 1% bovine serum albumin (SERVA, Germany) in 0.1% Tween-Tris-buffered saline. Figure S1 : A. Telemetric heart rate recordings in conscious freely moving C57BL/6J mice treated with rapamycin. At baseline and early after Uni-Nx+salt treatment, female mice tended to have slightly higher heart rates than males from week 1-4. Upon DOCA+salt+hydralazine + rapamycin treatment, heart rate differences were nearly eliminated (mean ± SEM, n=7). B. Invasive catheter measurements of mean arterial pressure in anesthetized mice were not different across groups. C. Cathetermeasured heart rates were also not different. D. Serum potassium concentrations in response to DOCA. E. Volume and water relationships in body composition studies. 
